China Medicine Corp banner

China Medicine Corp
OTC:CHME

Watchlist Manager
China Medicine Corp Logo
China Medicine Corp
OTC:CHME
Watchlist
Price: 0.02 USD Market Closed
Market Cap: $556.8k

China Medicine Corp
Total Current Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

China Medicine Corp
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
China Medicine Corp
OTC:CHME
Total Current Liabilities
$8.5m
CAGR 3-Years
92%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Total Current Liabilities
¥4.4B
CAGR 3-Years
19%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Total Current Liabilities
¥6.4B
CAGR 3-Years
21%
CAGR 5-Years
11%
CAGR 10-Years
20%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Total Current Liabilities
¥12.9B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
11%
Zhejiang Nhu Co Ltd
SZSE:002001
Total Current Liabilities
¥7.4B
CAGR 3-Years
-2%
CAGR 5-Years
3%
CAGR 10-Years
12%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Total Current Liabilities
¥2B
CAGR 3-Years
61%
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

China Medicine Corp
Glance View

Market Cap
556.8k USD
Industry
Pharmaceuticals

China Medicine Corp. engages in the development, manufacture, and sale of western pharmaceuticals, traditional Chinese medicines, and other healthcare products. The company is headquartered in Guangzhou, Guangdong and currently employs 281 full-time employees. The company went IPO on 2005-06-23. The firm is engaged in the production and distribution of prescription and over the counter (OTC) drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The firm is developing a number of products for a range of indications, including oncology, high blood pressure and the removal of toxins from food and animal feeds. The firm's products include Shuangdan Capsules, Houerhuan Anti-inflammatory Capsules, Shugan Yipi Granules, Danggui Tiaojing Granules, Huangzao Granules, Pingfeng Shengmai Capsules, Danqi Tablets and Naodesheng Tablets. The firm also offers a range of dietary supplements, which include BeThin Tablets, Refrelizer Herbal Tea, LifeFull Herbal Tea and Relaxetox Herbal Tea. Shuangdan Capsules are indicated for the treatment of stagnation of the heart blood, obstruction of qi in the chest and cardiodynia.

CHME Intrinsic Value
Not Available

See Also

What is China Medicine Corp's Total Current Liabilities?
Total Current Liabilities
8.5m USD

Based on the financial report for Sep 30, 2010, China Medicine Corp's Total Current Liabilities amounts to 8.5m USD.

What is China Medicine Corp's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
92%

Over the last year, the Total Current Liabilities growth was 134%. The average annual Total Current Liabilities growth rates for China Medicine Corp have been 92% over the past three years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett